Turnstone Biologics rides biotech’s IPO train in Friday debut

Turnstone Biologics raised $80 million in a Friday morning IPO under the ticker $TSBX, bookending a rare two-week stretch for biotech listings.

The startup follows Apogee Therapeutics, Sagimet Biosciences and 60 Degrees Pharmaceuticals in going public in recent days, a feat that…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks